Dr. Ashwin Pachaatt Vinod (@pachaatt) 's Twitter Profile
Dr. Ashwin Pachaatt Vinod

@pachaatt

Liver fellow, PGI Chandigarh. Alumnus AIIMS New Delhi/ Raipur.
प्रज्ञानं ब्रह्म,
आरोग्यम सुख संपदा,
शरीरमाद्यं खलु धर्मसाधनम्,
आर्त सेवा सर्वभद्र: शोधश च l

ID: 1412507868415234049

calendar_today06-07-2021 20:25:41

2,2K Tweet

881 Followers

1,1K Following

Elliot Tapper (@ebtapper) 's Twitter Profile Photo

Elevated ferritin? Is it hemochromatosis? Probably not! Join me for a quick-hit #livertwitter #tweetorial? First in a series on diagnostic testing for liver disease #meded

Elevated ferritin? Is it hemochromatosis? Probably not!

Join me for a quick-hit #livertwitter #tweetorial?

First in a series on diagnostic testing for liver disease #meded
TheLiverDoc (@theliverdr) 's Twitter Profile Photo

Good morning. The weekend witnessed a massive hate campaign directed against me by the pseudoscientific Ayurveda community as well as large account Indian right-wing influencers including "fellow doctor colleagues." They doxed my work place, threw religious slurs at me,

Good morning. 

The weekend witnessed a massive hate campaign directed against me by the pseudoscientific Ayurveda community as well as large account Indian right-wing influencers including "fellow doctor colleagues." 

They doxed my work place, threw religious slurs at me,
Swasti Rao ラオ スワスチイ (@swasrao) 's Twitter Profile Photo

TheLiverDoc Hi TheLiverDoc , Well all I can add from my personal experience is- my highly educated father, disciplined to the core kinda man, trained in yoga and a devout vegetarian- was diagnosed with 90 % blockage in all three main arteries two years ago. For an entire year, qualified

savykaur (@savykaur3) 's Twitter Profile Photo

Thrilled to announce the publication of our book on ‘Animal models of liver diseases’, produced in collaboration with Elsevier Dinesh M Tripathi! A valuable guide to all those working on rodent models of liver diseases EASL Education AASLD APASL News

Thrilled to announce the publication of our book on ‘Animal models of liver diseases’, produced in collaboration with <a href="/ElsevierConnect/">Elsevier</a> <a href="/DineshMTripathi/">Dinesh M Tripathi</a>! A valuable guide to all those working on rodent models of liver diseases <a href="/EASLedu/">EASL Education</a> <a href="/AASLDtweets/">AASLD</a> <a href="/APASLnews/">APASL News</a>
TheLiverDoc (@theliverdr) 's Twitter Profile Photo

Our invited chapter exhaustively written on microbiome and cirrhosis is out now, in this fantastic and highly recommended book on recent advances in cirrhosis and complications, from Elsevier-Academic Press, for pre-order. shop.elsevier.com/books/recent-a… PS: This is for clinicians,

Our invited chapter exhaustively written on microbiome and cirrhosis is out now, in this fantastic and highly recommended book on recent advances in cirrhosis and complications, from Elsevier-Academic Press, for pre-order. 

shop.elsevier.com/books/recent-a…

PS: This is for clinicians,
Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@absteward) 's Twitter Profile Photo

🧬 Dear taxonomists: Are we losing Candida? • Candida auris → Candidozyma auris • Candida krusei → Pichia kudriavzevii • Candida glabrata → Nakaseomyces glabrata • Candida lusitaniae → Clavispora lusitaniae • Candida kefyr → Kluyveromyces marxianus Brad Spellberg

ARPIT SHASTRI (@arpitshastri_78) 's Twitter Profile Photo

We report a rare case of congenital intrahepatic portosystemic shunt (CIPSS-Park's type I) manifested with HE in an adult . One should suspect it in absence of clinically significant liver disease, as early identification enables timely intervention. doi.org/10.1016/j.jceh…

We report a rare case of congenital intrahepatic portosystemic shunt (CIPSS-Park's type I) manifested with HE in an adult . One should suspect it in absence of clinically significant liver disease, as early identification enables timely intervention.
doi.org/10.1016/j.jceh…
JAMA Internal Medicine (@jamainternalmed) 's Twitter Profile Photo

This JAMA patient page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain. ja.ma/3GGn5Gr

This JAMA patient page covers #GLP1 weight-loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain. ja.ma/3GGn5Gr
Anand V Kulkarni (@anandvkulkarni2) 's Twitter Profile Photo

Rifaximin- no role in hospitalized or out patients. (Primary prophylaxis) pubmed.ncbi.nlm.nih.gov/37942950/ pubmed.ncbi.nlm.nih.gov/39190719/ Jasmohan Bajaj recently reported that even SBP secondary prophylaxis has no role. journals.lww.com/ctg/fulltext/2… pubmed.ncbi.nlm.nih.gov/39235290/

HEPATOLOGY Journal (@hep_journal) 's Twitter Profile Photo

Review Article From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury Allegretti et al. #LiverX tinyurl.com/y63vw9rf

Review Article

From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury

Allegretti et al.
#LiverX
tinyurl.com/y63vw9rf
TheLiverDoc (@theliverdr) 's Twitter Profile Photo

Hello! Since many were asking for the protein content from brands tested in both Citizens Protein Project One and Two, here they are summarized for you.

Hello! Since many were asking for the protein content from brands tested in both Citizens Protein Project One and Two, here they are summarized for you.
AJG - The American Journal of Gastroenterology (@amjgastro) 's Twitter Profile Photo

Vonoprazan High-dose Dual, Vonoprazan Triple and Rabeprazole Reverse Hybrid Therapies for First-line Treatment of H. pylori Infection: A Multicenter Randomized Trial Hsu, et al. 📕 doi.org/10.14309/ajg.0… Millie Long Jasmohan Bajaj

Vonoprazan High-dose Dual, Vonoprazan Triple and Rabeprazole Reverse Hybrid Therapies for First-line Treatment of H. pylori Infection: A Multicenter Randomized Trial
Hsu, et al.

📕 doi.org/10.14309/ajg.0…

<a href="/MLongMD/">Millie Long</a> <a href="/JasmohanBajaj/">Jasmohan Bajaj</a>
The Baveno Cooperation: an EASL Consortium (@bavenocoop) 's Twitter Profile Photo

CIRROXABAN Study is finally here! 🔬 First DB RCT evaluating rivaroxaban in cirrhosis 💡 Complication-free survival benefit in Child‑Pugh B7 (HR 0.26 [95 % CI 0.07–0.90]). ⚠️ Mild bleeding ↑, but no increase in severe events. 📄 journal-of-hepatology.eu/article/S0168-…

Dr Ashish Kumar (@drashish_kumar) 's Twitter Profile Photo

📣 Diabetes & Liver Symposium 🗓️ 26 July 2025 | 🕕 6–11 PM 📍 The Royal Plaza, New Delhi Struggling with #MASLD in #diabetes care? Learn real-world strategies, drug choices & guideline-based management from top experts. 📄 Early Free registration: tinyurl.com/4a36fwj5

📣 Diabetes &amp; Liver Symposium
🗓️ 26 July 2025 | 🕕 6–11 PM
📍 The Royal Plaza, New Delhi
Struggling with #MASLD in #diabetes care?
Learn real-world strategies, drug choices &amp; guideline-based management from top experts.
📄 Early Free registration: tinyurl.com/4a36fwj5
Aravind Palraj (@rheumat_aravind) 's Twitter Profile Photo

🧵 10 Rheumatology Diagnoses You Can Make Without a Single Positive Lab Yes — zero lab positivity. Because in rheumatology, clinical pattern is king. #RheumTwitter #MedTwitter #Autoimmune Dr Ihab Suliman Janet Pope

🧵 10 Rheumatology Diagnoses You Can Make Without a Single Positive Lab

Yes — zero lab positivity.
Because in rheumatology, clinical pattern is king.

#RheumTwitter #MedTwitter #Autoimmune <a href="/IhabFathiSulima/">Dr Ihab Suliman</a> <a href="/Janetbirdope/">Janet Pope</a>
Jessica Davis (@drjessicadavis) 's Twitter Profile Photo

📢Long-awaited CIRROXABAN is OUT! ➡️RCT ppx rivaroxaban, CP7:10, outcome death/tplt/decomp ➡️primary outcome 27% vs 47% (p=0.058) in AC ➡️similar bleeding, more nonpHTN bleeds in AC, RIV levels 100+ assoc w/bleeds ➡️kPa ⬇️ in AC group #livertwitter journal-of-hepatology.eu/article/S0168-…